ParkinSong: Outcomes of a 12-Month Controlled Trial of Therapeutic Singing Groups in Parkinson's Disease

Jeanette Tamplin; Meg E Morris; Caterina Marigliani; Felicity A Baker; Gustavo Noffs; Adam P Vogel

Journal article

ParkinSong: Outcomes of a 12-Month Controlled Trial of Therapeutic Singing Groups in Parkinson's Disease

Jeanette Tamplin, Meg E Morris, Caterina Marigliani, Felicity A Baker, Gustavo Noffs, Adam P Vogel

Journal of Parkinson's Disease | IOS Press | Published : 2020

DOI: 10.3233/JPD-191838

Download PDF

Abstract

Background: Parkinson’s disease (PD) frequently causes progressive deterioration in speech, voice and cognitive aspects of communication. These affect wellbeing and quality of life and are associated with caregiver strain and burden. Therapeutic singing groups can ameliorate PD-related communication disorders and increase social interaction and wellbeing for caregivers and care recipients. Objective: To analyse the effects of ParkinSong group singing sessions on Parkinson’s communication and wellbeing outcomes for people with PD and caregivers over 12 months. Methods: A 4-armed controlled clinical trial compared ParkinSong with active non-singing control conditions over 12 months. Two dosa..

View full abstract

University of Melbourne Researchers

Jeanette Tamplin Author

Felicity Baker Author

Gustavo Noffs Author

Adam Vogel Author

Related Projects (2)

CHOIR PARTICIPATION TO IMPROVE WELLBEING AND RELATIONSHIP QUALITY FOR COMMUNITY-DWELLING PEOPLE WITH DEMENTIA AND THEIR PRIMARY CARE-GIVERS

An estimated 300,000 Australians live with dementia and this figure is projected to triple by 2050. Aligning with government priorities to s..

OPTIMISING SPEECH ASSESSMENT AND TREATMENT IN FRONTOTEMPORAL DEMENTIA

Frontotemporal dementia has a devastating impact on our ability to speak and understand others. This proposal aims to improve our understand..

Grants

Awarded by National Health and Medical Research Council Fellowships

Funding Acknowledgements

This research was funded by The University of Melbourne, La Trobe University, and Parkinson's Victoria (Australia). J Tamplin and A Vogel were supported by National Health and Medical Research Council Fellowships (#1106603 and #1135683 respectively). We would like to acknowledge and thank Monash Health and the Hugh Williamson Foundation for their support of this research. Special thanks also to the people living with Parkinson's who gave so generously of their time to participate in this research.